News | January 15, 2014

ROI Awards Malolan Rajagopalan Grant to Develop Website, Mobile App to Track Radiotherapy Toxicity

January 15, 2014 — The Radiation Oncology Institute (ROI) has selected Malolan S. Rajagopalan, M.D., radiation oncology resident, University of Pittsburgh Cancer Institute, to receive a $20,000 grant for a project to compile best practices regarding the management of radiation therapy toxicity. Rajagopalan’s project proposal includes development of a website and mobile application that will give ROI the capability to continually update this material so that it will remain current. Combined, the website and mobile app will be comprehensive tools that will improve patient quality of life and treatment outcomes.
 
Rajagopalan and his team will develop the website and a mobile app, for Apple iOS phones and tablets, to allow physicians, nurses and physician assistants to quickly review and implement symptom management pathways and guidelines for patients and provide links to peer-reviewed literature and areas in need of further study. The site will provide comprehensive information, recommendations with evidence links and other published articles. The site will be structured to be a living document that selected experts will update. The mobile app will also include a drug prescription reference tailored for oncology, as well as a number of tools and references to guide clinicians on the go.
 
Rajagopalan’s team will form a multidisciplinary panel of radiation oncology specialists and various other fields such as palliative care and pulmonology to review all materials to ensure the quality and comprehensiveness of the information and resources provided. Each panel of approximately four to six members will include radiation oncologists from various institutions and, for diversity, at least one member who is not a radiation oncologist. The first two symptoms that will be addressed are the most prevalent side effects of radiation therapy: dermatitis and oral mucositis.
 
Together, the website and mobile app will compile and categorize both acute and late radiation symptom management strategies, and prioritize them by effectiveness and the levels of evidence that support them. Rajagopalan plans to unveil both for beta review and testing Sept. 14-17, 2014 at ASTRO’s 56th Annual Meeting in San Francisco.
 
“A multidisciplinary cancer treatment plan includes thorough consideration and accounting for the individual needs of each patient, particularly when treatment side effects significantly impact patient compliance and outcomes,” said ROI President Theodore Lawrence, M.D., Ph.D., FASTRO, and president, ROI. “We are excited that Rajagopalan’s project will provide us with the best approaches to mitigating adverse treatment effects and a platform that will permit us to continue to grow this valuable resource.”
 
For more information: www.roinstitute.org

Related Content

Veterans Integrated Service Network 19 Implements System-Wide Radiation Dose Monitoring
News | Radiation Dose Management | December 04, 2018
Agfa HealthCare announced it has collaborated in delivering a system-wide DoseMonitor automated software implementation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...